New clinical Trial open for patients with B-Cell LymphomaAmie Connor
Do you or a loved one suffer from a B-Cell lymphoma which has relapsed, or is no longer responding to standard treatment?
A new, phase 1, first inhuman study has opened this week at LINEAR: TG-1801-101
Patients with relapsed or refractory B-Cell Lymphoma will receive weekly infusions of TG-1801 for the first 2 cycles (2 months) and then monthly infusions, for a total of 6 months maximum treatment.
For more information please visit our “Trials open for recruitment page” https://www.bloodcancerwa.org.au/trial/tg-1801/ or please contact LINEAR Haematology Clinical Trials: E – email@example.com – T: +61 (08) 9386 5125 / 6382 5127